Corrigendum: Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma.
Corrigendum: Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma.
复制标题
DOI：
10.1038/srep46645
复制
发表时间：
2017-04-21
影响因子：
4.6
通讯作者：
Canettieri G
中科院分区：
文献类型：
--
作者：
Coni S;Mancuso AB;Di Magno L;Sdruscia G;Manni S;Serrao SM;Rotili D;Spiombi E;Bufalieri F;Petroni M;Kusio-Kobialka M;De Smaele E;Ferretti E;Capalbo C;Mai A;Niewiadomski P;Screpanti I;Di Marcotullio L;Canettieri G
""